Skip to main content Skip to section navigation Skip to footer
Stock Information
chevron_left Back to CastleBiosciences.com
Castle Biosciences, Inc. IR Home
  • Overview
  • News & Events keyboard_arrow_down
    • Press Releases
    • IR Events
    • Presentations
    • In The Media
    • Annual Meeting
    • Email Alerts
  • Company Info keyboard_arrow_down
    • Company Profile
    • Executive Team
    • Annual Reports & Proxy
    • Contacts
    • FAQ
  • Financial Info keyboard_arrow_down
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data keyboard_arrow_down
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings keyboard_arrow_down
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance keyboard_arrow_down
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Corporate Responsibility
  • Resources keyboard_arrow_down
    • Scientific Evidence
  • Stock Information
  • chevron_leftBack to CastleBiosciences.com

In The Media

News & Events

  • Press Releases
  • IR Events
  • Presentations
  • In The Media
  • Annual Meeting
  • Email Alerts
Oct 2, 2025
The CEO Magazine: Announcing the Winners of the 2025 Executive of the Year Awards – United States
Sep 26, 2025
The Pathologist Power List 2025: Matthew Goldberg
Sep 25, 2025
Healio: Genomic Test Predicts Metastasis Risk After Squamous Cell Carcinoma Diagnosis
Sep 16, 2025
Technology Networks: AI-Enabled Spatial Proteomics Improves Cancer Prediction
Sep 11, 2025
PharmaPhorum: Spatialomics and AI: A New Age for Personalised Clinical Medicine
Aug 27, 2025
Targeted Oncology: DecisionDx-SCC Improves Risk Stratification in High-Risk CSCC
Aug 26, 2025
Cancer Network: DecisionDx-SCC Predicts Recurrence, Guides Imaging in Squamous Cell Carcinoma
Aug 25, 2025
Dermatology Times: New Studies Expand Clinical Role of DecisionDx-SCC in High-Risk cSCC
Aug 25, 2025
Cure Today: DecisionDx-SCC Test Helps Predict Outcomes in High-Risk Skin Cancer
Aug 20, 2025
Dermatology Times: Unpacking the Role of Gene Expression Profiling in Melanoma
rss_feed RSS
  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 26
  • Next Pagearrow_forward
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
©2026 Castle Biosciences, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement

Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.